Vermillion Inc (VRML.OQ)

VRML.OQ on NASDAQ Stock Exchange Capital Market

1.39USD
17 Dec 2014
Price Change (% chg)

$-0.03 (-2.11%)
Prev Close
$1.42
Open
$1.45
Day's High
$1.45
Day's Low
$1.37
Volume
1,867
Avg. Vol
6,439
52-wk High
$3.79
52-wk Low
$1.20

VRML.OQ

Chart for VRML.OQ

About

Vermillion, Inc. is engaged in the discovery, development and commercialization of diagnostic tests that helps physicians diagnose, treat and improve outcomes for patients. The Company's tests are intended to help guide decisions regarding patient treatment, which may include decisions to refer patients to specialists, to... (more)
No analyst recommendations are available for VRML.OQ.

Overall

Beta: 1.62
Market Cap (Mil.): $51.51
Shares Outstanding (Mil.): 36.02
Dividend: --
Yield (%): --

Financials

  VRML.OQ Industry Sector
P/E (TTM): -- 176.92 37.62
EPS (TTM): -0.49 -- --
ROI: -145.81 -0.38 17.39
ROE: -148.55 -1.43 18.30
Search Stocks

Competitors

  Price Change
Abbott Laboratories (ABT.N) $44.26 +0.86
Becton, Dickinson and Co. (BDX.N) $136.80 +2.76
Arrayit Corp (ARYC.PK) $0.12 -0.03
Pfizer Inc. (PFE.N) $31.12 +0.45

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: Wright Reports
$75.00
Provider: S&P Capital IQ Quantitative Report
$115.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks